NCT04954040 - Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19 | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

October 31, 2021

Study Completion Date

December 31, 2021

Conditions

Acute Respiratory Distress SyndromeCovid19

Interventions

DRUG

Hydroxychloroquine Pill + Azithromycin Pill

"Hydroxychloroquine. 1st day 200mg 2-0-2; 2nd to 5th day 200mg 1-0-1 Azithromycin.~1st day 500m 0-1-0, 2nd to 5th day 250mg 0-1-0"

DRUG

SOC

Acetaminophen or Metamizole. Antitussives if needed.

Trial Locations (1)

RECRUITING

Centro de Salud Priego de Córdoba, Priego de Córdoba